Europe can achieve herd immunity against the virus within three to four months, the head of German pharmaceutical company BioNTech, developer of the first widely approved inoculation with U.S. partner Pfizer, said Wednesday.
Europe can achieve herd immunity against the virus within three to four months, the head of German pharmaceutical company BioNTech, developer of the first widely approved inoculation with U.S. partner Pfizer, said Wednesday.
Headlines with a Voice 